Susan Hasty, Publisher
Table of Contents . . . December 1st, 2003
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Hepatitis Weekly | Other Publications
Endocrinology - Interferon improves insulin dynamics in chronic hepatitis B and C responders
Stem-Cell Research - Bone marrow-derived cells offer little hope for repairing damaged livers
Addiction Medicine - Methadone users need access to orthotopic liver transplantations
Pain Medicine - Patients with liver diseases report having upper abdominal pain symptoms
Transplantation - Where livers and kidneys are both needed liver transplants should be done first
Addiction Medicine - Patients with alcoholic etiologies fare worse in a study of steatohepatitis
Antisense Drugs - Company updates positive clinical data on multiple antisense drugs
Cancer Metastasis - Gene therapy containing p53 combines with CDDP to arrest liver tumor growth
Cancer Risk Factors - Hepatitis B virus genes promote liver cancer in chronic hepatitis C patients
Chronic Hepatitis C - Tissue regeneration may drive HCV recurrence after liver transplantation
Collaborations - Pennsylvania partnership announces agreement to build relationship with Roche
Fatty Liver Disease - Long-term rosiglitazone improves the markers of nonalcoholic steatohepatitis
Finance - Actimmune maker announces third quarter financial results
Gastroenterology - Outcomes with hepatitis C- and B-core antibody-positive grafts are good
Hematopoietic Cell Transplant - Keeping DC immaturity may induce tolerance for transplant of hematopoietic cells
Hepatitis A Virus - New study finds universal vaccination would prevent disease and save lives
Hepatitis B Vaccine - Aspergillus niger effective host for virus-like particle production
Hepatitis C Virus - Companies enter hepatitis C virus license agreement
Hepatitis C Virus - Pharmaceutical company to initiate phase III clinical trials for Viramidine
Hepatitis C Virus - Researchers reveal essential component of immunity to liver-destroying virus
Hepatitis Therapy - Nasal or rectal administration of glycyrrhizin offers good bioavailability
Hepatitis Virus - Interferon-alpha down-regulates collagen production and stems liver fibrosis
Inoperable Liver Cancer - Liver cirrhosis with inoperable liver cancer treated by intratumor ethanol, IL-2
Mergers and Acquisitions - Net Force signs letter of intent to acquire Chinese biotech company
Occupational Health - Healthcare workers experience a decline in blood and body fluid exposures
Oncology - Reactive oxygen species exacerbate the effects of hepatitis B virus X protein
Phytotherapy - Saikosaponins from Bupleurum exhibit antiviral and anticancer properties
Protein Processing - Hepatitis C virus core protein assembles in the nucleus of yeast
Transplant Medicine - Crystalline particles seen in University of Wisconsin perfusion solution
Transplantation - HCV recurrence reflects low sequence diversity after liver transplantation
Transplantation - Neither liver transplantation nor HCV contraindicate renal transplant
Viral Genomics - Alternative translation schemes control hepatitis C ARFP/F/core +1 coding
Viral Proteomics - Hepatitis C envelope glycoprotein E2 requires heparan sulfate for cell binding
Virology - Sodium stibogluconate inhibits authentic hepatitis C virus replication
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.